Novo Nordisk - Saxenda Provides Added Value That The Market May Not Appreciate

Novo Nordisk - Saxenda Provides Added Value That The Market May Not Appreciate

Novo Nordisk has secret weapons of sorts when it comes to entering the anti-obesity space. The first secret weapon is that the main ingredient in the anti-obesity drug Saxenda is the same ingredient, liraglutide, in the already successful diabetes drug Victoza.

from Biotech News